Uni-Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches 肌顏態®: Pioneering Entry into the High-Growth Medical Aesthetics Market

  • 📰 theSundaily
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

Media Outreach Newswire ニュース

日本 最新ニュース,日本 見出し

HONG KONG SAR - EQS Newswire - 2 December 2024 - Uni-Bio Science Group Limited (the “Company”, together with its subsidiaries, the “Group”) is pleased...

Uni-Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches 肌顏態®: Pioneering Entry into the High-Growth Medical Aesthetics Market

The Group’s strategic cooperation product with Chongqing Minji Medical Device Co., Ltd., recombinant collagen dressing, has successfully received Class II medical device approval, with the approval number “渝械注准 20242140377”. At the same time, the Group’s self-developed medical aesthetics product, 肌顏態®, was successfully launched, marked by a grand event held in Wuhan.

The debut of肌顏態® has attracted high recognition and attention from many dermatologists and medical aesthetics practitioners.

These achievements reflect the Group’s strong commitment to innovation, strategic execution, and value creation. As the Group continues to execute its strategic vision, it remains focused on its goal of becoming China’s leading expert in dermatology, leveraging innovation, clinical expertise, and market insight to drive sustainable growth and long-term success.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 25. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し